Evidence map›Paper›PMID 32331211›Full record

ArticleInternational journal of molecular sciences2020

Praeruptorin B Mitigates the Metastatic Ability of Human Renal Carcinoma Cells through Targeting CTSC and CTSV Expression.

Chia-Liang Lin, Tung-Wei Hung, Tsung-Ho Ying, Chi-Jui Lin, Yi-Hsien Hsieh, Chien-Min Chen

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Fungal isolates influence the quality ofFrontiers in plant science · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Chia-Liang LinInstitute of Biochemistry, Microbiology and Immunology, Chung Shan Medical University, Taichung 40201, Taiwan.
Tung-Wei HungDivision of Nephrology, Department of Medicine, Chung Shan Medical University Hospital, Taichung 40201, Taiwan.
Tsung-Ho YingDepartment of Obstetrics and Gynecology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan.ORCID 0000-0001-8244-7524
Chi-Jui LinInstitute of Biochemistry, Microbiology and Immunology, Chung Shan Medical University, Taichung 40201, Taiwan.
Yi-Hsien HsiehInstitute of Biochemistry, Microbiology and Immunology, Chung Shan Medical University, Taichung 40201, Taiwan.ORCID 0000-0003-4942-1888
Chien-Min ChenDivision of Neurosurgery, Department of Surgery, Changhua Christian Hospital, Changhua 50006, Taiwan.
Chung Shan Medical University Hospital · TWMackay Medical University · TWDayeh University · TW

Funding

Changhua Christian Hospital 108-CCH-IRP-013
6 · The paper itself

Abstract

Renal cell carcinoma (RCC) is the most common adult kidney cancer, and accounts for 85% of all cases of kidney cancers worldwide. Praeruptorin B (Pra-B) is a bioactive constituent of

Indexed as

Carcinoma, Renal CellCathepsin CCathepsinsCell Line, TumorCell MovementCell ProliferationCell SurvivalCoumarinsCysteine EndopeptidasesEpidermal Growth FactorGene Expression Regulation, NeoplasticHumansKidney NeoplasmsMAP Kinase Signaling SystemModels, BiologicalMolecular StructureanomalinCathepsin CCathepsinsCoumarinsCTSC protein, humanCTSV protein, humanCysteine EndopeptidasesEpidermal Growth FactorCTSCCTSVinvasionmigrationPraeruptorin-Brenal cell carcinoma

Identifiers

PMID32331211
PMCPMC7216260
OpenAlexW3018635791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.